Zheplastan (Gelplastan)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppowder for topical application
Composition:1 bottle contains

Plasma of blood of cattle

0.175 g

0.35 g

Kanamycin monosulfate

0.075 g

0.15 g

Gelatin food

up to 2,5 g

up to 5.0 g
Description:Amorphous-crystalline powder from yellow to dark yellow with a specific odor.
Pharmacotherapeutic group:Hemostatic agent for topical application
ATX: & nbsp
  • Gelatin absorbent sponge
    • Pharmacodynamics:Zhelplastan is an absorbent hemostatic agent for topical application. The drug accelerates the process of thrombosis at the site of application, has antibacterial activity, is absorbed in the tissues of the body.
    Indications:To achieve hemostasis and "gluing" of tissues, especially with extensive damages of the parenchymal organs (for example, the liver, spleen, kidneys), as well as with open musculoskeletal injuries.
    Contraindications:Hypersensitivity to the components of the drug; children's age (<18 years); congenital and acquired disorders of the blood coagulation system.
    Dosing and Administration:Zheplastan is used topically. The bottle with the drug is opened immediately before use. Immediately after drainage of the bleeding wound surface, the powder is applied evenly and pressed gauze with a tissue until it stopsbleeding. If the thickness of the powder layer is insufficient, the surface of the surface may be incurvated blood. In this case, you should raise the gauze pad and add additional amount of the drug to the bleeding sites and then squeeze again. After the final stop of bleeding, the excess drug is removed. The dose of the drug depends on the intensity of bleeding and the area of ​​the wound surface. The maximum drug consumption per patient usually does not exceed 15 g, but it can be used in a larger dose.
    Side effects:Allergic reactions.
    Overdose:There are no reports of overdose cases. Since the content of active components is very small, cases of overdose with Zheplastan are virtually impossible.
    Interaction:Interactions with other drugs have not been established.
    Special instructions:

    Zheplastan is available in sterile bottles. Use only undamaged packaging. Repeated sterilization is not possible.

    The production of the drug uses raw materials from animals that have no bacterial, mycoplasmal, prion, and viral etiology, pathogenic to humans.Do not use drugs that reduce blood clotting, while using Zhelplastan.

    Form release / dosage:Powder for topical application at 2.5 and 5 g.
    Packaging:In bottles of neutral glass with a capacity of 5 and 10 ml, corked with rubber stoppers and rolled with aluminum caps. 10 vials with instructions for use are placed in a cardboard box, the packets are placed in a group package.
    Storage conditions:In a dry, protected from light place at a temperature of no higher than 25 ° C. Keep out of the reach of children.
    Shelf life:

    3 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-004765/07
    Date of registration:13.12.2007 / 03.03.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:TANAIS NGO, LLC TANAIS NGO, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp17.05.2017
    Illustrated instructions
      Instructions
      Up